MARYÁŠ, Josef, Michal MASAŘÍK and Pavel BOUCHAL. PDZ and LIM domain protein 2 (PDLIM2) is connected to epithelial-to-mesenchymal transition in breast cancer. In 1st Joint EACR-MRS Conference Seed and Soil: In Vivo Models of Metastasis. November 27-29, 2017, Berlin, Germany - Clinical and Experimental Metastasis, vol. 34, No. 8, Springer, 2018, 497-497. 2017. ISSN 0262-0898.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name PDZ and LIM domain protein 2 (PDLIM2) is connected to epithelial-to-mesenchymal transition in breast cancer
Authors MARYÁŠ, Josef, Michal MASAŘÍK and Pavel BOUCHAL.
Edition 1st Joint EACR-MRS Conference Seed and Soil: In Vivo Models of Metastasis. November 27-29, 2017, Berlin, Germany - Clinical and Experimental Metastasis, vol. 34, No. 8, Springer, 2018, 497-497. 2017.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.455
Organization unit Faculty of Science
ISSN 0262-0898
UT WoS 000429931800024
Keywords in English PDLIM2; EMT; metastasis; luminal A breast cancer; hypoxia; MCF10A cells
Tags International impact
Changed by Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 9/1/2019 21:50.
Abstract
PDZ and LIM domain protein 2 (PDLIM2), a member of the ALP protein family, is a cytoskeletal and nuclear protein that regulates the activity of several transcription factors, e.g., NF-kappaB and STAT. Its deregulation was observed in several malignancies. PDLIM2 expression was shown epigenetically repressed by promoter hypermetylation in different cancers, nonetheless, PDLIM2 is also highly expressed in invasive cancer: we recently identified PDLIM2 as a protein associated with lymph node metastasis in luminal A breast cancer. Here we aimed to unravel these contradictory mechanisms in breast cancer models. First, we studied and confirmed a promoting role of PDLIM2 in epithelial-to-mesenchymal transition (EMT) in MCF7 cells, a model of luminal A tumors, which was accompanied by increased cell rigidity. However, in MCF10A cells, a model of normal breast epithelium, PDLIM2 helped to maintain epithelial phenotype. Furthermore, exposition of MCF7 cells to hypoxic conditions was able to increase PDLIM2 protein levels, but no such effect was observed in MCF10A cells. Likewise, PDLIM2 overexpression significantly increased cell migration, invasion, and proliferation in MCF7 cells but decreased proliferation and increased adhesion in MCF10A cells. These data indicate a context dependent role of PDLIM2 which may play a tumour suppressor role in early phase of tumour development but oncoprotein role in later phase of tumorigenesis. Our latest data from in vivo mice model further support this hypothesis.
Links
GA17-05957S, research and development projectName: Evaluace nových potenciálních cílů a inhibitorů pro blokování vývoje metastáz u luminálních A nádorů prsu
Investor: Czech Science Foundation
MUNI/A/1278/2016, interní kód MUName: Podpora biochemického výzkumu v roce 2017
Investor: Masaryk University, Category A
PrintDisplayed: 16/9/2024 20:33